Fig. 4From: Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trialTime to event curve in cumulative incidences of the definite or probable stent thrombosis. Hazard ratios and P values are derived from Cox proportional hazard methodsBack to article page